Cargando…

The use of historical priors to improve the efficiency of phase II clinical trials with time-to-event endpoints

Detalles Bibliográficos
Autores principales:	Jackson, Richard, Cox, Trevor, Tudur-Smith, Catrin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980365/ http://dx.doi.org/10.1186/1745-6215-14-S1-P53

Ejemplares similares

The consensus studysquamous cell carcinoma of the oropharynx: late phase clinical trials; core outcomes
por: Waters, Aoife, et al.
Publicado: (2013)

Independent endpoint event review for the elimination of reporting bias in an open label phase III pharmaceutical trial
por: Hall, Peter, et al.
Publicado: (2015)

The CONSENSUS Study: Preliminary results of a mixed methods study to develop a core outcome set for late phase clinical trials in Oropharyngeal Cancer
por: Waters, Aoife M I, et al.
Publicado: (2015)

Improving phase ii oncology trial using best observed RECIST response as an endpoint by modelling continuous tumour measurements
por: Lin, Chien-Ju, et al.
Publicado: (2015)

Elicitation of expert prior opinion: application to the mypan trial in childhood polyarteritis nodosa
por: Hampson, Lisa, et al.
Publicado: (2014)

The trials and tribulations of accessing data from routine sources
por: Powell, Graham, et al.
Publicado: (2015)

Simulation study - handling missing covariates in the context of external validation
por: Bonnett, Laura J, et al.
Publicado: (2011)

Feasibility of establishing a central repository for the individual participant data from research studies
por: Smith, Catrin Tudur, et al.
Publicado: (2011)

Clinical trials in rare diseases: a review of practice
por: Bell, Stuart, et al.
Publicado: (2013)

Mixed response and time-to-event endpoints for multistage single-arm phase II design
por: Lai, Xin, et al.
Publicado: (2015)

Individual participant data meta-analyses compared with meta-analyses based on aggregate data
por: Smith, Catrin Tudur, et al.
Publicado: (2011)

Phosphocreatine recovery time constant (PCr) at peak exercise as a potential endpoint for clinical trials in PAD
por: Gonzalez, Jorge A, et al.
Publicado: (2016)

Analysis of composite endpoints in gene expression studies in oncology
por: Marhoon, ZA, et al.
Publicado: (2015)

Statistical evaluation of surrogate endpoints: a systematic review
por: Ensor, Hannah, et al.
Publicado: (2013)

External validation of a prognostic index
por: Bonnett, Laura, et al.
Publicado: (2013)

A robust parameterisation for the analysis of survival data in the presence of covariates with extreme value observations
por: Jackson, Richard, et al.
Publicado: (2011)

Modifying the multi-arm multi-stage (MAMS) design for use in a phase II tuberculosis trial in sub-Saharan Africa with a time-to-event primary outcome
por: Phillips, Patrick, et al.
Publicado: (2013)

CMR endpoints for clinical trials: impact of operator experience on the accuracy of image analysis
por: McAlindon, Elisa, et al.
Publicado: (2012)

Time-to-event studies: how robust are inferences when the assumption of independent censoring is in doubt?
por: Law, Martin, et al.
Publicado: (2015)

An adaptive seamless phase II/III clinical trial design incorporating short-term endpoint information
por: Stallard, Nigel
Publicado: (2011)

The feasibility and validity of a preference-weighted composite endpoint to establish value in geriatric care
por: Hofman, Cynthia, et al.
Publicado: (2014)

Endpoint resuscitation-based prediction model for early mortality of severe sepsis and septic shock
por: Sinto, R, et al.
Publicado: (2014)

A two-stage design for phase II trials with time-to-event endpoint using restricted follow-up
por: Belin, Lisa, et al.
Publicado: (2017)

The win ratio method: a novel hierarchical endpoint for pneumonia trials in patients on mechanical ventilation
por: Montgomery, A, et al.
Publicado: (2014)

Joint models for longitudinal and time-to-event data: a review of reporting quality with a view to meta-analysis
por: Sudell, Maria, et al.
Publicado: (2016)

Correction to: joint models for longitudinal and time-to-event data: a review of reporting quality with a view to meta-analysis
por: Sudell, Maria, et al.
Publicado: (2018)

Simulation work in adaptive dose-finding designs to identify dose-intervals that achieve targets in multiple endpoints
por: Howlett, James, et al.
Publicado: (2015)

Information-theoretic model averaging: a useful method for modelling exploratory secondary endpoints in clinical trials
por: Lythgoe, Daniel
Publicado: (2013)

Use of an online e-learning module to standardise the assessment and reporting of a subjective endpoint in a multicentre rct
por: Pinkney, Thomas, et al.
Publicado: (2013)

Normative Visual Development: efficient coding principles for adult V1 predict properties of LGN waves prior to eye opening
por: Albert, Mark V, et al.
Publicado: (2010)

Experiences in the design and implementation of phase II trials in CLL
por: Cohen, Dena R, et al.
Publicado: (2011)

The importance of historical data in simulating malaria epidemiology and control interventions: application to multiple sites in Madagascar
por: Pothin, Emilie, et al.
Publicado: (2014)

The timing of new acute hemodynamic events in ICU patients
por: Kersten, A, et al.
Publicado: (2004)

A Phase I study of AD5-GUCY2C-PADRE in stage I and II colon cancer patients
por: Snook, Adam, et al.
Publicado: (2015)

Efficient analysis of time-to-event endpoints when the event involves a continuous variable crossing a threshold
por: Lin, Chien-Ju, et al.
Publicado: (2020)

Investigation of 2‐stage meta‐analysis methods for joint longitudinal and time‐to‐event data through simulation and real data application
por: Sudell, Maria, et al.
Publicado: (2017)

Investigation of one‐stage meta‐analysis methods for joint longitudinal and time‐to‐event data through simulation and real data application
por: Sudell, Maria, et al.
Publicado: (2018)

Efficient estimation of phase response curves via compressive sensing
por: Hong, Sungho, et al.
Publicado: (2011)

Development of a comprehensive new endpoint for the evaluation of new treatments for acute decompensated heart failure: results with levosimendan in the REVIVE 1 study
por: Garratt, C, et al.
Publicado: (2004)

Testing the equivalence of survival distributions using PP- and PPP-plots
por: Cox, Trevor
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mcusj4p087nc5e4ao4tospb9b9